RCM
Riverhead Capital Management Portfolio holdings
AUM
$2.71B
This Quarter Return
+1.42%
1 Year Return
+2.36%
3 Year Return
+45.73%
5 Year Return
+71.19%
10 Year Return
–
AUM
$2.71B
AUM Growth
+$2.71B
(-0.12%)
Cap. Flow
-$25.2M
Cap. Flow
% of AUM
-0.93%
Top 10 Holdings %
Top 10 Hldgs %
12.6%
Holding
1,579
New
62
Increased
514
Reduced
352
Closed
83
Top Buys
| 1 |
iShares Russell 2000 ETF
IWM
|
$20M |
| 2 |
Johnson & Johnson
JNJ
|
$8.95M |
| 3 |
AT&T
T
|
$7.43M |
| 4 |
Microsoft
MSFT
|
$7.31M |
| 5 |
Citigroup
C
|
$6.5M |
Top Sells
| 1 |
MetLife
MET
|
$7.51M |
| 2 |
Robert Half
RHI
|
$6.99M |
| 3 |
Ally Financial
ALLY
|
$6M |
| 4 |
Fortinet
FTNT
|
$5.99M |
| 5 |
OGE Energy
OGE
|
$4.8M |
Sector Composition
| 1 | Technology | 17.94% |
| 2 | Financials | 14.81% |
| 3 | Healthcare | 13.01% |
| 4 | Industrials | 10.57% |
| 5 | Consumer Discretionary | 10.38% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Clorox
CLX
$15B
| $15.4M | 0.57% |
101,184
-4,460
| -4% | -$677K |
|
27
Mastercard
MA
$536B
| $15.1M | 0.56% |
55,486
+5,355
| +11% | +$1.45M |
|
28
Bank of America
BAC
$371B
| $14.6M | 0.54% |
499,929
+89,928
| +22% | +$2.62M |
|
29
UnitedHealth
UNH
$279B
| $14.4M | 0.53% |
66,401
+7,065
| +12% | +$1.54M |
|
30
Alphabet (Google) Class C
GOOG
$2.79T
| $14.1M | 0.52% |
231,920
+56,400
| +32% | +$3.44M |
|
31
Thermo Fisher Scientific
TMO
$183B
| $13.9M | 0.51% |
47,772
+494
| +1% | +$144K |
|
32
Amgen
AMGN
$153B
| $13.1M | 0.48% |
67,452
+3,576
| +6% | +$692K |
|
33
Motorola Solutions
MSI
$79B
| $13M | 0.48% |
76,007
-4,400
| -5% | -$750K |
|
34
Broadcom
AVGO
$1.42T
| $12.9M | 0.48% |
468,130
+83,970
| +22% | +$2.32M |
|
35
Biogen
BIIB
$20.8B
| $12.6M | 0.47% |
54,118
-9,931
| -16% | -$2.31M |
|
36
Intel
INTC
$105B
| $12.6M | 0.46% |
243,920
-49,692
| -17% | -$2.56M |
|
37
Target
TGT
$42B
| $12.5M | 0.46% |
117,219
+1,899
| +2% | +$203K |
|
38
Cummins
CMI
$54B
| $12.4M | 0.46% |
76,495
-15,293
| -17% | -$2.49M |
|
39
iShares Core S&P 500 ETF
IVV
$660B
| $12.3M | 0.45% |
41,084
-10,803
| -21% | -$3.22M |
|
40
Sysco
SYY
$38.8B
| $11.9M | 0.44% |
150,217
+14,077
| +10% | +$1.12M |
|
41
SPDR S&P 500 ETF Trust
SPY
$656B
| $11.5M | 0.42% |
38,718
+6,200
| +19% | +$1.84M |
|
42
Bristol-Myers Squibb
BMY
$96.7B
| $11.4M | 0.42% |
225,463
+70,818
| +46% | +$3.59M |
|
43
Applied Materials
AMAT
$124B
| $10.9M | 0.4% |
219,250
+9,013
| +4% | +$450K |
|
44
Goldman Sachs ActiveBeta US Large Cap Equity ETF
GSLC
$14.1B
| $10.7M | 0.4% |
179,397
+1,886
| +1% | +$113K |
|
45
Gilead Sciences
GILD
$140B
| $10.3M | 0.38% |
163,064
+35,850
| +28% | +$2.27M |
|
|
46
MetLife
MET
$53.6B
| $10.3M | 0.38% |
217,796
-159,210
| -42% | -$7.51M |
|
47
Xerox
XRX
$478M
| $10.3M | 0.38% |
342,691
+111,450
| +48% | +$3.33M |
|
48
Oracle
ORCL
$628B
| $9.98M | 0.37% |
181,338
+47,721
| +36% | +$2.63M |
|
49
F5
FFIV
$17.8B
| $9.97M | 0.37% |
71,016
-33,564
| -32% | -$4.71M |
|
50
Delta Air Lines
DAL
$40B
| $9.82M | 0.36% |
170,453
+30,219
| +22% | +$1.74M |
|